News
-
-
PRESS RELEASE
Affluent Medical : 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap
Affluent Medical reached major new milestones in executing its clinical roadmap in 2024, including transformative agreements and positive FDA feedback. Financial results show progress and strategic appointments -
PRESS RELEASE
2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap
Affluent Medical announces major milestones in its 2024 full-year results including transformative agreements, regulatory validations, and clinical advancements, positioning the company for market launch -
-
PRESS RELEASE
Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women.
Affluent Medical progresses towards European clinical study of Artificial Sphincter Artus for treating Urinary Stress Incontinence in Women. The upcoming SPHINX study will assess device safety and performance -
PRESS RELEASE
Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women
Affluent Medical progresses towards European clinical study of Artus artificial sphincter for treating urinary stress incontinence in women. Minimally invasive procedure feasibility confirmed -
-
-
-
PRESS RELEASE
Affluent Medical announces several key appointments for Medical and Clinical affairs.
Affluent Medical announces key appointments for Medical and Clinical affairs, including Dr. Howard C. Herrmann and Pr. Nicolas Barry Delongchamps. Federica Azzimonti joins as Director of Clinical Operations. Aiming to accelerate the company's progress towards market access